Burosumab-twza Subcutaneous and Dextroamphetamine Sustained-Release Capsules
Determining the interaction of Burosumab-twza Subcutaneous and Dextroamphetamine Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: dextroamphetamine
Brand name: Dexedrine Spansule, ProCentra, Zenzedi, Dexedrine, Dextrostat, Liquadd
Synonyms: Dextroamphetamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Dextroamphetamine Tablets
- Burosumab-twza Subcutaneous-Dextromethorphan
- Burosumab-twza Subcutaneous-Dextromethorphan and Chlorpheniramine Chewable Tablets
- Burosumab-twza Subcutaneous-Dextromethorphan and Chlorpheniramine Liquid and Syrup
- Burosumab-twza Subcutaneous-Dextromethorphan and Chlorpheniramine Tablets
- Burosumab-twza Subcutaneous-Dextromethorphan and doxylamine
- Dextroamphetamine Sustained-Release Capsules-Buspar
- Dextroamphetamine Sustained-Release Capsules-Buspar Dividose
- Dextroamphetamine Sustained-Release Capsules-Buspirone
- Dextroamphetamine Sustained-Release Capsules-Buspirone Hydrochloride
- Dextroamphetamine Sustained-Release Capsules-Busulfan
- Dextroamphetamine Sustained-Release Capsules-Busulfan Concentrate Injection